Author

Ciara C O Sullivan

Observed name: Ciara C. O’ Sullivan

Institution: Mayo Clinic

Observed institution: Mayo Clinic

OpenAlex ID: A5015175340

Abstract OT2-19-05: A phase I/II trial of abemaciclib and T-DM1 in women and men with HER2-positive advanced or metastatic breast cancer that has progressed on treatment with a taxane, trastuzumab and pertuzumab (THP) (ACCRU-BR-1801)

2022 · Ciara C O Sullivan, Jun He, et al. · Cancer Research

Abstract P4-01-03: Multiomics data reveal novel biomarkers for CDK4/6 resistance

2022 · Krishna R. Kalari, Kevin J. Thompson, et al. · Cancer Research

Abstract PS5-24: Novel genomic variants and pathways associated with baseline serum thymidine kinase 1 levels in HR-positive HER2-negative MBC patients commencing palbociclib and letrozole

2021 · Ciara C O Sullivan, Krishna R Kalari, et al. · Cancer Research

Abstract P2-11-07: Comprehensive tumor sequencing to identify biomarkers of palbociclib response: First report of the PROMISE study

2020 · Ciara C O Sullivan, Krishna R Kalari, et al. · Cancer Research

Works count: 4

Citation count:

H-index:

I10-index: